Accretion Pharmaceuticals (NSE:ACCPL) General and Admin. Expense: ₹0.0 Mil (TTM As of Mar. 2026)


NSE:ACCPL Accretion Pharmaceuticals Ltd NSE:ACCPL
18 GF Score
Price ₹162.00
! 6 Warning Signs
View Full Analysis

What is Accretion Pharmaceuticals General and Admin. Expense?

Accretion Pharmaceuticals NSE:ACCPL -4.14% 18 General and Admin. Expense is ₹0.0 Mil as of Mar. 2026. GuruFocus rates NSE:ACCPL with a GF Score™ of 18/100. The stock has 6 warning signs investors should review.

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Accretion Pharmaceuticals's General and Admin. Expense for the six months ended in Mar. 2026 was ₹0.0 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0.0 Mil.

Accretion Pharmaceuticals General and Admin. Expense Related Terms

Accretion Pharmaceuticals General and Admin. Expense Historical Data

* Premium members only.

The historical data trend for Accretion Pharmaceuticals's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Accretion Pharmaceuticals General and Admin. Expense Chart

Accretion Pharmaceuticals Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
General and Admin. Expense
0.65 1.40 2.24 0.00 0.00

Accretion Pharmaceuticals Semi-Annual Data
Mar22 Mar23 Mar24 Sep24 Mar25 Sep25 Mar26
General and Admin. Expense Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
NSE:ACCPL
18GF Score
Accretion Pharmaceuticals Ltd NSE:ACCPL
General and Admin. Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Accretion Pharmaceuticals General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a General and Admin. Expense of ₹0.0 Mil mean?
Accretion Pharmaceuticals (NSE:ACCPL) has a General and Admin. Expense of ₹0.0 Mil as of Mar. 2026. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Accretion Pharmaceuticals and its competitors.
Is Accretion Pharmaceuticals' General and Admin. Expense too high?
Accretion Pharmaceuticals' current General and Admin. Expense is ₹0.0 Mil. Overall, Accretion Pharmaceuticals has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Accretion Pharmaceuticals' General and Admin. Expense compare to LLY and JNJ?
Accretion Pharmaceuticals' General and Admin. Expense of ₹0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good General and Admin. Expense for a Drug Manufacturers company?
A good General and Admin. Expense depends on the Drug Manufacturers industry context. However, General and Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high General and Admin. Expense mean?
A high General and Admin. Expense can signal that a stock is expensive relative to its fundamentals. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Accretion Pharmaceuticals and its competitors. Accretion Pharmaceuticals's current General and Admin. Expense is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Accretion Pharmaceuticals stock overvalued right now?
Accretion Pharmaceuticals (NSE:ACCPL) has a current General and Admin. Expense of ₹0.0 Mil. The current General and Admin. Expense is ₹0.0 Mil. Accretion Pharmaceuticals' overall GF Score™ is 18/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is General and Admin. Expense calculated?
General and Admin. Expense is calculated from a company's financial statements. For Accretion Pharmaceuticals (NSE:ACCPL), the current General and Admin. Expense is ₹0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Accretion Pharmaceuticals Business Description

Address 29, Xcelon Industrial Park-1, Behind Intas Pharmaceuticals, Vasna-Chacharwadi, Ta - Sanand District, Ahmedabad, GJ, IND, 382213
Accretion Pharmaceuticals Ltd is engaged in the manufacturing of Medicinal & Pharmaceutical Products. The company manufactures tablets, oral liquid, capsule, cream, ointment, mouthwash, dusting powder, gel, ear drops, lotion, shampoo, powder, syrup, among others.
18GF Score

Get the complete analysis for NSE:ACCPL

General and Admin. Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹162.00
Price